LumaMed is developing “Polarization Subtraction Imaging” (PSI), a novel patented technology that provides rapid, intra-operative digital imaging of the surface of tissue excised during cancer surgery. PSI uses non-ionizing visible light for geometric optical sectioning and imaging of the superf...

Tweet

First Warning Systems, Inc. (FWSI) has developed a non-invasive, non-compressive and non-radiogenic device and service designed to detect early breast tissue abnormalities prior to measureable tumor formation at the current standard of care. The science behind the device process is described as Disc...

Tweet

Bartron Medical Imaging, Inc. is a high technology company formed to develop, test, and manufacture, MED-SEG™ an award winning, FDA class II cleared medical device. Bartron Medical Imaging, Inc. (BMI) believes that we have developed a series of products and a system that can provide unique assis...

Tweet

The Constitutional Theory of Chinese Medicine allows you to make a diagnosis of the imbalance of the five elements of a patient. The cancer has its origins in an imbalance of blood. The weak immune system allows cancer cells to survive and multiply. Disequilibrium analysis gives indications for trea...

Tweet

Hyperthermia (also called thermal therapy or thermotherapy) is a type of cancer treatment in which body tissue is exposed to high temperatures (up to 113°F). Research has shown that high temperatures can damage and kill cancer cells, usually with minimal injury to normal tissues. By killing cancer ...

Tweet

The Near-infrared Image Diagnostic Analyzer is a noninvasive, portable, radiation-free device that computes the light diffusion of suspicious breast lesions by recording near-infrared image and calculates different wavelength image single use CCD or CMOS sensors. This algorithm has the advantage of ...

Tweet

Proteomic markers that can distinguish breast cancer from other solid tumor cancers with high levels of sensitivity and specificity through a non-invasive blood test would be a valuable tool for physicians when used in conjunction with current imaging techniques. ProteaSure is an early-stage cancer ...

Tweet

Early diagnosis of breast cancer is a critical step in the pathway to better prognosis for women with breast cancer. Every year, 1.6 million Australian women attend BreastScreen Australia for free mammographic screening. However, women with high levels of mammographically dense breast tissue are at ...

Tweet

Triple negative breast cancers (TNBCs) comprise 12-25% of newly diagnosed breast cancer cases. They pose a great challenge in making treatment decisions and their prognosis is mostly poor. Most targeted breast cancer therapies don’t work in TNBC, the only promising targeted agent against TNBC is b...

Tweet

In our previous study, we have established a breast ultrasound image database. In this study, we will continue to expand the database, and add the information about patient’s molecular typing. For the CAD system, the project intends to combine the data mining and pattern recognition techniques wit...

Tweet